{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T04:10:26Z","timestamp":1746677426493,"version":"3.40.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,7]]},"DOI":"10.7759\/cureus.83663","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T14:10:58Z","timestamp":1746627058000},"source":"Crossref","is-referenced-by-count":0,"title":["The Accuracy of Biparametric Prostate MRI in the Pathway of Patients With Prostate Cancer"],"prefix":"10.7759","author":[{"given":"Radu T","family":"Ion","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandru","family":"Serbanoiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alecsandra Iulia","family":"Salcianu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Narcisa","family":"Popa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florin Mihail","family":"Filipoiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M","family":"Bratu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","author":"Ferlay J","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, Bray F. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021, 10.1002\/ijc.33588","journal-title":"Int J Cancer"},{"key":"ref2","unstructured":"Cancer facts & figures 2024. Accessed. December 16, 2024: https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/2024-cancer-facts-figures.html."},{"key":"ref3","unstructured":"Prostate gland & seminal vesicles. Accessed. December 16, 2024: https:\/\/www.pathologyoutlines.com\/topic\/prostateadenoNOS.html."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-019-0212-4","article-title":"Multiparametric MRI for prostate cancer diagnosis: current status and future directions","volume":"17","author":"Stabile A","year":"2020","unstructured":"Stabile A, Giganti F, Rosenkrantz AB, et al.. Multiparametric MRI for prostate cancer diagnosis: current status and future directions. Nat Rev Urol. 2020, 17:41-61. 10.1038\/s41585-019-0212-4","journal-title":"Nat Rev Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.prnil.2019.12.004","article-title":"Biparametric versus multiparametric magnetic resonance imaging of the prostate: detection of clinically significant cancer in a perfect match group","volume":"8","author":"Cho J","year":"2020","unstructured":"Cho J, Ahn H, Hwang SI, Lee HJ, Choe G, Byun SS, Hong SK. Biparametric versus multiparametric magnetic resonance imaging of the prostate: detection of clinically significant cancer in a perfect match group. Prostate Int. 2020, 8:146-51. 10.1016\/j.prnil.2019.12.004","journal-title":"Prostate Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11071223","article-title":"Comparison of sensitivity and specificity of biparametric versus multiparametric prostate MRI in the detection of prostate cancer in 431 men with elevated prostate-specific antigen levels","volume":"11","author":"Pesapane F","year":"2021","unstructured":"Pesapane F, Acquasanta M, Meo RD, et al.. Comparison of sensitivity and specificity of biparametric versus multiparametric prostate MRI in the detection of prostate cancer in 431 men with elevated prostate-specific antigen levels. Diagnostics (Basel). 2021, 11:1223. 10.3390\/diagnostics11071223","journal-title":"Diagnostics (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02230-y","article-title":"Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients","volume":"20","author":"Merriel SW","year":"2022","unstructured":"Merriel SW, Pocock L, Gilbert E, Creavin S, Walter FM, Spencer A, Hamilton W. Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients. BMC Med. 2022, 20:54. 10.1186\/s12916-021-02230-y","journal-title":"BMC Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2019-0693","article-title":"Biomarkers for prostate cancer: prostate-specific antigen and beyond","volume":"58","author":"Duffy MJ","year":"2020","unstructured":"Duffy MJ. Biomarkers for prostate cancer: prostate-specific antigen and beyond. Clin Chem Lab Med. 2020, 58:326-39. 10.1515\/cclm-2019-0693","journal-title":"Clin Chem Lab Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-020-02482-x","article-title":"PI-RADS: what is new and how to use it","volume":"45","author":"Dutruel SP","year":"2020","unstructured":"Dutruel SP, Jeph S, Margolis DJ, Wehrli N. PI-RADS: what is new and how to use it. Abdom Radiol (NY). 2020, 45:3951-60. 10.1007\/s00261-020-02482-x","journal-title":"Abdom Radiol (NY)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-020-03310-z","article-title":"Role of multiparametric prostate MRI in the management of prostate cancer","volume":"39","author":"O'Connor LP","year":"2021","unstructured":"O'Connor LP, Lebastchi AH, Horuz R, et al.. Role of multiparametric prostate MRI in the management of prostate cancer. World J Urol. 2021, 39:651-9. 10.1007\/s00345-020-03310-z","journal-title":"World J Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07008-z","article-title":"Clinically significant prostate cancer detection and segmentation in low-risk patients using a convolutional neural network on multi-parametric MRI","volume":"30","author":"Arif M","year":"2020","unstructured":"Arif M, Schoots IG, Castillo Tovar J, et al.. Clinically significant prostate cancer detection and segmentation in low-risk patients using a convolutional neural network on multi-parametric MRI. Eur Radiol. 2020, 30:6582-92. 10.1007\/s00330-020-07008-z","journal-title":"Eur Radiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders GJ","year":"2020","unstructured":"van Leenders GJ, van der Kwast TH, Grignon DJ, et al.. The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma. Am J Surg Pathol. 2020, 44:e87-99. 10.1097\/PAS.0000000000001497","journal-title":"Am J Surg Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/17434440.2020.1755257","article-title":"Use of multiparametric magnetic resonance imaging (mpMRI) in localized prostate cancer","volume":"17","author":"O'Connor L","year":"2020","unstructured":"O'Connor L, Wang A, Walker SM, Yerram N, Pinto PA, Turkbey B. Use of multiparametric magnetic resonance imaging (mpMRI) in localized prostate cancer. Expert Rev Med Devices. 2020, 17:435-42. 10.1080\/17434440.2020.1755257","journal-title":"Expert Rev Med Devices"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-019-02302-x","article-title":"Prostate MR: pitfalls and benign lesions","volume":"45","author":"Chatterjee A","year":"2020","unstructured":"Chatterjee A, Thomas S, Oto A. Prostate MR: pitfalls and benign lesions. Abdom Radiol (NY). 2020, 45:2154-64. 10.1007\/s00261-019-02302-x","journal-title":"Abdom Radiol (NY)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.10.024","article-title":"Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to know. Part 2: interpretation","volume":"77","author":"Isra\u00ebl B","year":"2020","unstructured":"Isra\u00ebl B, Leest MV, Sedelaar M, Padhani AR, Z\u00e1mecnik P, Barentsz JO. Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to know. Part 2: interpretation. Eur Urol. 2020, 77:469-80. 10.1016\/j.eururo.2019.10.024","journal-title":"Eur Urol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.09.021","article-title":"Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to know. Part 1: acquisition","volume":"77","author":"Engels RR","year":"2020","unstructured":"Engels RR, Isra\u00ebl B, Padhani AR, Barentsz JO. Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to know. Part 1: acquisition. Eur Urol. 2020, 77:457-68. 10.1016\/j.eururo.2019.09.021","journal-title":"Eur Urol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.21037\/gs-20-547","article-title":"Biparametric (bp) and multiparametric (mp) magnetic resonance imaging (MRI) approach to prostate cancer disease: a narrative review of current debate on dynamic contrast enhancement","volume":"9","author":"Palumbo P","year":"2020","unstructured":"Palumbo P, Manetta R, Izzo A, et al.. Biparametric (bp) and multiparametric (mp) magnetic resonance imaging (MRI) approach to prostate cancer disease: a narrative review of current debate on dynamic contrast enhancement. Gland Surg. 2020, 9:2235-47. 10.21037\/gs-20-547","journal-title":"Gland Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.27283","article-title":"Comparison of biparametric and multiparametric mri for clinically significant prostate cancer detection with PI\u2010RADS version 2.1","volume":"53","author":"Tamada T","year":"2021","unstructured":"Tamada T, Kido A, Yamamoto A, Takeuchi M, Miyaji Y, Moriya T, Sone T. Comparison of biparametric and multiparametric mri for clinically significant prostate cancer detection with PI\u2010RADS version 2.1. J Magn Reson Imaging. 2021, 53:283-91. 10.1002\/jmri.27283","journal-title":"J Magn Reson Imaging"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-020-00298-w","article-title":"A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk","volume":"24","author":"Bass EJ","year":"2021","unstructured":"Bass EJ, Pantovic A, Connor M, et al.. A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk. Prostate Cancer Prostatic Dis. 2021, 24:596-611. 10.1038\/s41391-020-00298-w","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-07907-9","article-title":"Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the G\u00f6teborg prostate cancer screening 2 trial","volume":"31","author":"Wallstr\u00f6m J","year":"2021","unstructured":"Wallstr\u00f6m J, Geterud K, Kohestani K, et al.. Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the G\u00f6teborg prostate cancer screening 2 trial. Eur Radiol. 2021, 31:8692-702. 10.1007\/s00330-021-07907-9","journal-title":"Eur Radiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-022-03750-8","article-title":"The diagnostic performance in clinically significant prostate cancer with PI-RADS version 2.1: simplified bpMRI versus standard mpMRI","volume":"48","author":"Song J","year":"2023","unstructured":"Song J, Zhao C, Zhang F, et al.. The diagnostic performance in clinically significant prostate cancer with PI-RADS version 2.1: simplified bpMRI versus standard mpMRI. Abdom Radiol (NY). 2023, 48:704-12. 10.1007\/s00261-022-03750-8","journal-title":"Abdom Radiol (NY)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-020-00373-4","article-title":"Detecting recurrent prostate cancer using multiparametric MRI, influence of PSA and Gleason grade","volume":"21","author":"Venkatesan AM","year":"2021","unstructured":"Venkatesan AM, Mudairu-Dawodu E, Duran C, Stafford RJ, Yan Y, Wei W, Kundra V. Detecting recurrent prostate cancer using multiparametric MRI, influence of PSA and Gleason grade. Cancer Imaging. 2021, 21:3. 10.1186\/s40644-020-00373-4","journal-title":"Cancer Imaging"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/355469-the-accuracy-of-biparametric-prostate-mri-in-the-pathway-of-patients-with-prostate-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T14:11:04Z","timestamp":1746627064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/355469-the-accuracy-of-biparametric-prostate-mri-in-the-pathway-of-patients-with-prostate-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.83663","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,7]]}}}